Latest Indonesia News

Cokal returned to coal sales at its BBM project during FY2026, but regulatory suspensions and weak cash generation pushed the company to a US$11.3 million loss and US$29.6 million of net liabilities. An auditor-highlighted material uncertainty over going concern remains, despite a post-year-end extension of major debt repayments.

NuEnergy Gas is moving its Tanjung Enim coal bed methane project towards targeted first gas sales in early 2027, backed by a US$88 million field service contract. But the ASX-listed developer ended FY2026 with only A$552,509 in cash, substantial liabilities and a material uncertainty around its ability to continue as a going concern.

Ocean Sciences delivered a sharp increase in seaweed revenue during FY2026, but the audited report also records a A$1.612 million continuing-operations loss, A$2.319 million operating cash outflow and material uncertainty over its ability to continue as a going concern. The renamed ASX-listed group is now seeking up to A$3 million while building out its Indonesian platform.

Cokal’s 60%-owned BBM subsidiary has pushed repayment of a US$20 million capital sum from January 2027 to January 2030. The relief comes with deferred fees carrying 10% annual interest and marketing rights over the first 20 million tonnes of mine production.

SportsHero’s FY2026 revenue rose above A$1 million as HeroPlay gained traction through Southeast Asian telco partnerships. But the company remains deeply loss-making, burned A$1.9 million in operating cash and carries a material uncertainty over its ability to continue as a going concern.

Bass Oil says production at its Indonesian Bunian field has risen from 250 bopd to more than 800 bopd on a 100% share basis after Bunian 6 began producing from a newly discovered reservoir. Output could reach about 1,000 bopd once additional trucking capacity is available.

Nico Resources is advancing drilling, metallurgical studies and a potential downstream battery-materials partnership at Wingellina, despite a subdued nickel market and a larger annual loss. The company ended FY2026 with $4.73 million across cash and short-term investments after raising $3.73 million in equity.

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

Bass Oil’s Bunian 6 well has confirmed oil in a previously unproduced zone, with the company targeting a potential threefold increase in Tangai-Sukananti field production. August sales also improved as Cooper Basin exports resumed, while Vanessa and Kiwi advanced toward future gas development.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Estrella Resources has expanded its Timor-Leste exploration footprint by 100km2 while securing conditional approval to export a 100-tonne manganese sample to an Indonesian customer. The company is also preparing 3,000 metres of drilling and a possible upgrade to part of its 621Mt Werumata limestone resource.

Horizon Oil has used its Pareto Securities presentation to put record FY26 production, enlarged reserves and a multi-country drilling pipeline at the centre of its growth case. The stronger platform comes with a test: convert a long list of projects into sustained cash flow while preserving shareholder returns.